Dexcom receives FDA clearance for G7 15 Day glucose monitoring system
The G7 continuous glucose monitoring system will have a 15.5-day wear time and last 15% longer than Dexcom G7, according to the company.
Related Articles
ConcertAI, Bayer join forces to advance precision oncology
The alliance combines ConcertAI’s data platform with Bayer’s scientific and AI expertise.
Study: Racial, ethnic minorities are underrepresented in AI mammogram
A study published in the European Journal of Cancer says inaccurate results and misdiagnoses could occur if diverse populations are not included in clinical research.
Phantom Neuro secures $19M to advance human-machine technology
The company’s minimally invasive muscle-machine interface, Phantom X, allows one to control prosthetic limbs and robotic exoskeletons as extensions of the human body.
Thyroid cancer AI assistant developed in Hong Kong
Claimed to be a world’s first, the LLM-driven model has demonstrated over 90% accuracy.
Reimagine Care, MedStar Health partner to integrate oncology care
The alliance will allow MedStar Health to extend its cancer care services and provide symptom management, remote patient monitoring and supportive care.
Culina Health partners with Adventist HealthCare Physician Alliance
The alliance aims to prevent diet-related diseases by expanding access to virtual nutrition counseling and registered dietitians.
hellocare.ai scores $47M for AI-enabled virtual care for smart
The hospital-focused telehealth and virtual care delivery company, which currently works with more than 70 health systems, will use the funds to scale its reach.
Hinge Health, Cigna Healthcare partner amid IPO push
The San Francisco-based musculoskeletal care platform will be included in Cigna’s offerings for self-insured employers.
Cleveland Clinic to build new hospital in Vietnam: 5 notes – Becker’s Hospital Review | Healthcare News & Analysis
Cleveland Clinic has partnered with Vinmec Healthcare System in Vietnam to build a new hospital in the country. The two organizations plan to break ground…
Eko Health expands digital stethoscope platform to UK market
Clinicians in the UK now have access to the company’s AI-powered cardiac and pulmonary assessment tools via the company’s website and Amazon UK.